| XELJANZ 1 mg/mL oral solution EU/1/17/1178/015 |
TOFACITINIB |
Pfizer Europe MA EEIG |
— |
| XELJANZ 10 mg film-coated tablets EU/1/17/1178/005-009 |
Tofacitinib citrate |
Pfizer Europe MA EEIG |
— |
| XELJANZ 11 mg film-coated tablets EU/1/17/1178/010-013 |
TOFACITINIB |
Pfizer Europe MA EEIG |
— |
| XELJANZ 5 mg film-coated tablets EU/1/17/1178/001-003 |
Tofacitinib citrate |
Pfizer Europe MA EEIG |
— |
| Xeloda 150 mg film-coated tablets EU/1/00/163/001 |
Capecitabine |
Cheplapharm Arzneimittel GmbH |
— |
| Xeloda 500 mg film-coated tablets EU/1/00/163/002 |
Capecitabine |
Cheplapharm Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/001 |
Orlistat |
Cheplapharm Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/002 |
Orlistat |
CHEPLAPHARM Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/003 |
Orlistat |
Cheplapharm Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/004 |
Orlistat |
Cheplapharm Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/005 |
Orlistat |
Cheplapharm Arzneimittel GmbH |
— |
| Xenical 120 mg hard capsules EU/1/98/071/006 |
Orlistat |
Cheplapharm Arzneimittel GmbH |
— |
| Xenleta 150 mg concentrate for solution for infusion EU/1/20/1457/001 |
Lefamulin |
Nabriva Therapeutics Ireland Designated Activity Company |
— |
| Xenleta 600 mg film-coated tablets EU/1/20/1457/002 |
Lefamulin |
Nabriva Therapeutics Ireland Designated Activity Company |
— |
| Xenpozyme 20 mg powder for concentrate for solution for infusion EU/1/22/1659/001-004 |
Olipudase Alfa |
Sanofi B.V. |
— |
| XEOMIN 100 units powder for solution for injection PA1907/001/002 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| XEOMIN 200 units powder for solution for injection PA1907/001/003 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| XEOMIN 50 units powder for solution for injection PA1907/001/001 |
Clostridium botulinum neuro-toxin type a (150 kd), free from complexing proteins |
Merz Pharmaceuticals GmbH |
Marketed |
| Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/004 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection EU/1/11/672/005 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 150 mg prolonged-release suspension for injection Xeplion 100 mg prolonged-release suspension for injection EU/1/11/672/006 |
Paliperidone, Paliperidone |
Janssen-Cilag International NV |
— |
| Xeplion 25 mg prolonged-release suspension for injection EU/1/11/672/001 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 50 mg prolonged-release suspension for injection EU/1/11/672/002 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xeplion 75 mg prolonged-release suspension for injection EU/1/11/672/003 |
Paliperidone palmitate (r092670) |
Janssen-Cilag International NV |
— |
| Xerava 100 mg Powder for concentrate for solution for infusion EU/1/18/1312/003-004 |
ERAVACYCLINE |
Paion Pharma GmbH |
— |
| Xerava 50 mg Powder for concentrate for solution for infusion EU/1/18/1312/001 |
ERAVACYCLINE |
Paion Pharma GmbH |
— |
| Xermelo 250 mg film-coated tablets EU/1/17/1224/001-002 |
Telotristat etiprate |
Serb S.A.S. |
— |
| XGEVA 120 mg solution for injection EU/1/11/703/001-002 |
Denosumab |
Amgen Europe B.V., |
— |
| Xigduo 5 mg/1000 mg film-coated tablets EU/1/13/900/007-012 |
Metformin Hydrochloride, Dapagliflozin propanediol monohydrate |
AstraZeneca AB |
— |
| Xigduo 5 mg/850 mg film-coated tablets EU/1/13/900/001-006 |
Dapagliflozin propanediol monohydrate, Metformin Hydrochloride |
AstraZeneca AB |
— |
| Xiliarx 50 mg tablets EU/1/08/486/1-11 |
Vildagliptin |
Novartis Europharm Limited |
— |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/001 |
Ranibizumab |
Stada Arzneimittel AG |
— |
| Ximluci 10 mg/mL solution for injection EU/1/22/1691/002 |
Ranibizumab |
Stada Arzneimittel AG |
— |
| Xoanacyl 1 g film-coated tablets EU/1/25/1923/001 |
Ferric citrate coordination complex |
Averoa |
— |
| Xofigo 1100 kBq/mL solution for injection EU/1/13/873/001 |
Radium-223 chloride |
Bayer AG |
— |
| Xofluza 2 mg/mL granules for oral suspension EU/1/20/1500/005 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 20 mg film-coated tablets EU/1/20/1500/001 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 40 mg film-coated tablets EU/1/20/1500/002 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xofluza 80 mg film-coated tablets EU/1/20/1500/003 |
Baloxavir Marboxil |
Roche Registration GmbH |
— |
| Xolair 150 mg powder and solvent for solution for injection EU/1/05/319/002 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 150 mg solution for injection in pre-filled syringe EU/1/05/319/8-10 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 300 mg solution for injection in pre-filled pen EU/1/05/319/015-017 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 300 mg solution for injection in pre-filled syringe EU/1/05/319/012-014 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 75 mg powder and solvent for solution for injection EU/1/05/319/001 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xolair 75 mg solution for injection in pre-filled syringe EU/1/05/319/5-7 |
Omalizumab |
Novartis Europharm Limited |
— |
| Xospata 40 mg film-coated tablets EU/1/19/1399/001 |
Gilteritinib fumarate |
Astellas Pharma Europe B.V. |
— |
| Xoterna Breezhaler 85 micrograms/43 micrograms inhalation powder hard capsules EU/1/13/863/001-006 |
Indacaterol maleate, Glycopyrronium bromide |
Novartis Europharm Limited |
— |
| Xromi 100 mg/ml oral solution EU/1/19/1366/001 |
Hydroxycarbamide |
Lipomed GmbH |
— |
| Xtandi 40 mg film-coated tablets EU/1/13/846/002 |
Enzalutamide |
Astellas Pharma Europe B.V. |
— |
| Xtandi 40 mg soft capsules EU/1/13/846/001 |
Enzalutamide |
Astellas Pharma Europe BV |
— |